Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1988 1
1992 2
1993 3
1995 2
1996 2
1997 1
1998 1
2000 1
2001 1
2002 3
2003 4
2004 7
2005 2
2006 4
2007 5
2008 5
2009 7
2010 9
2011 10
2012 9
2013 10
2014 6
2015 7
2016 8
2017 7
2018 2
2019 8
2020 10
2021 10
2022 8
2023 12
2024 5
2025 5

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

154 results

Results by year

Filters applied: . Clear all
Page 1
Venetoclax Plus Rituximab in Relapsed Chronic Lymphocytic Leukemia: 4-Year Results and Evaluation of Impact of Genomic Complexity and Gene Mutations From the MURANO Phase III Study.
Kater AP, Wu JQ, Kipps T, Eichhorst B, Hillmen P, D'Rozario J, Assouline S, Owen C, Robak T, de la Serna J, Jaeger U, Cartron G, Montillo M, Dubois J, Eldering E, Mellink C, Van Der Kevie-Kersemaekers AM, Kim SY, Chyla B, Punnoose E, Bolen CR, Assaf ZJ, Jiang Y, Wang J, Lefebure M, Boyer M, Humphrey K, Seymour JF. Kater AP, et al. Among authors: eldering e. J Clin Oncol. 2020 Dec 1;38(34):4042-4054. doi: 10.1200/JCO.20.00948. Epub 2020 Sep 28. J Clin Oncol. 2020. PMID: 32986498 Free PMC article. Clinical Trial.
Serpin B9 controls tumor cell killing by CAR T cells.
Kimman T, Slomp A, Martens A, Grabherr S, Li S, van Diest E, Meeldijk J, Kuball J, Minnema MC, Eldering E, Bovenschen N, Sebestyén Z, Peperzak V. Kimman T, et al. Among authors: eldering e. J Immunother Cancer. 2023 Mar;11(3):e006364. doi: 10.1136/jitc-2022-006364. J Immunother Cancer. 2023. PMID: 36931661 Free PMC article.
Redirecting T-cell Activity with Anti-BCMA/Anti-CD3 Bispecific Antibodies in Chronic Lymphocytic Leukemia and Other B-cell Lymphomas.
Martens AWJ, Rietveld JM, de Boer R, Peters FS, Ngo A, van Mil LWHG, de Heer K, Spaargaren M, Verkleij CPM, van de Donk NWCJ, Adams HC 3rd, Eldering E, van Noesel CJM, Verona R, Kater AP. Martens AWJ, et al. Among authors: eldering e. Cancer Res Commun. 2022 May 9;2(5):330-341. doi: 10.1158/2767-9764.CRC-22-0083. eCollection 2022 May. Cancer Res Commun. 2022. PMID: 36875718 Free PMC article.
Longitudinal omics data and preclinical treatment suggest the proteasome inhibitor carfilzomib as therapy for ibrutinib-resistant CLL.
Arseni L, Sigismondo G, Yazdanparast H, Hermansen JU, Mack N, Ohl S, Kalter V, Iskar M, Kalxdorf M, Friedel D, Rettel M, Paul Y, Ringshausen I, Eldering E, Dubois J, Kater AP, Zapatka M, Roessner PM, Tausch E, Stilgenbauer S, Dietrich S, Savitski MM, Skånland SS, Krijgsveld J, Lichter P, Seiffert M. Arseni L, et al. Among authors: eldering e. Nat Commun. 2025 Jan 26;16(1):1041. doi: 10.1038/s41467-025-56318-7. Nat Commun. 2025. PMID: 39863584 Free PMC article.
Disruption of constitutive CXCR4 oligomers impairs oncogenic properties in lymphoid neoplasms.
Mobach S, Bergkamp ND, Ma Z, Haselager MV, Anbuhl SM, Jurriens D, van den Bor J, Wang Z, Crudden C, Roos JL, Perez Almeria CV, Boergonje RA, Lohse MJ, Bosma R, Eldering E, Siderius M, Wu W, Spaargaren M, Tonino SH, Kater AP, Smit MJ, Heukers R. Mobach S, et al. Among authors: eldering e. Proc Natl Acad Sci U S A. 2025 Jun 17;122(24):e2424186122. doi: 10.1073/pnas.2424186122. Epub 2025 Jun 11. Proc Natl Acad Sci U S A. 2025. PMID: 40498456
Elevated Fab glycosylation of autoantibodies maintained during B cell depletion therapy.
Valk AM, Koers J, Derksen NIL, Hogenboom L, van Kempen Z, Killestein J, Rutgers A, Heeringa P, Horváth B, Kuijpers TW, van Ham SM, Brinke AT, van der Woude D, Toes REM, Bos NA, Rispens T; T2B consortium. Valk AM, et al. Sci Rep. 2025 Apr 28;15(1):14770. doi: 10.1038/s41598-025-99226-y. Sci Rep. 2025. PMID: 40295683 Free PMC article.
Cholesterol homeostasis and lipid raft dynamics at the basis of tumor-induced immune dysfunction in chronic lymphocytic leukemia.
Jacobs CF, Peters FS, Camerini E, Cretenet G, Rietveld J, Schomakers BV, van Weeghel M, Hahn N, Verberk SGS, Van den Bossche J, Langeveld M, Kleijwegt F, Eldering E, Zelcer N, Kater AP, Simon-Molas H. Jacobs CF, et al. Among authors: eldering e. Cell Mol Immunol. 2025 May;22(5):485-500. doi: 10.1038/s41423-025-01262-1. Epub 2025 Mar 4. Cell Mol Immunol. 2025. PMID: 40033083 Free PMC article.
154 results